Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Acute Chest Syndrome
|
135 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.020 | 2 | 2009 | 2015 | |||||
Alzheimer Disease, Late Onset
|
243 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.010 | 1 | 2011 | 2011 | |||||
Cerebral Infarction
|
123 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.010 | 1 | 2016 | 2016 | |||||
Complications of Diabetes Mellitus
|
35 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.010 | 1 | 2006 | 2006 | |||||
Congestive heart failure
|
165 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.010 | 1 | 2019 | 2019 | |||||
Heart failure
|
201 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.010 | 1 | 2019 | 2019 | |||||
Hyperlipidemia
|
83 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.010 | 1 | 2011 | 2011 | |||||
Obstructive sleep apnea hypopnea syndrome
|
7 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.010 | 1 | 2011 | 2011 | |||||
Retinal Diseases
|
56 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.010 | 1 | 2017 | 2017 | |||||
Alzheimer's Disease
|
1843 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.060 | 0.500 | 6 | 2005 | 2015 | ||||
Lipodystrophy
|
28 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.020 | 0.500 | 2 | 2009 | 2014 | ||||
Rectal Carcinoma
|
112 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.020 | 0.500 | 2 | 2005 | 2010 | ||||
Diabetic Retinopathy
|
213 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.050 | 0.600 | 5 | 2005 | 2017 | ||||
Myocardial Infarction
|
680 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.050 | 0.600 | 5 | 2003 | 2015 | ||||
Diabetic Nephropathy
|
238 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.060 | 0.667 | 6 | 2007 | 2012 | ||||
Malignant neoplasm of prostate
|
1082 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.030 | 0.667 | 3 | 2003 | 2015 | ||||
Prostate carcinoma
|
1168 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.030 | 0.667 | 3 | 2003 | 2015 | ||||
Ulcerative Colitis
|
827 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.030 | 0.667 | 3 | 2010 | 2014 | ||||
Hypertensive disease
|
1085 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.070 | 0.714 | 7 | 2001 | 2019 | ||||
Colon Carcinoma
|
275 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.040 | 0.750 | 4 | 2005 | 2017 | ||||
Inflammatory Bowel Diseases
|
605 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.040 | 0.750 | 4 | 2008 | 2012 | ||||
Malignant tumor of colon
|
688 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.040 | 0.750 | 4 | 2005 | 2017 | ||||
Coronary heart disease
|
1178 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.090 | 0.778 | 9 | 2005 | 2013 | ||||
Non-alcoholic Fatty Liver Disease
|
222 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.090 | 0.778 | 9 | 2010 | 2014 | ||||
Polycystic Ovary Syndrome
|
363 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.100 | 0.789 | 19 | 2002 | 2019 |